Relating to care fund income.
Submitted by the Cemetery Board.
hist161069Report received from Agency, January 3, 2023. hist161241Referred to the committee on Financial Institutions and Sporting Heritage, January 13, 2023. Relating to long-term care services and Medical Assistance fair hearing process.
Submitted by the Department of Health Services.
hist161067Report received from Agency, January 3, 2023. hist161242Referred to the committee on Health, January 13, 2023. Relating to licensure requirements.
Submitted by the Occupational Therapists Affiliated Credentialing Board.
hist161066Report received from Agency, January 3, 2023. hist161243Referred to the committee on Licensing, Constitution and Federalism, January 13, 2023. Relating to continuing education.
Submitted by the Occupational Therapists Affiliated Credentialing Board.
hist161065Report received from Agency, January 3, 2023. hist161244Referred to the committee on Licensing, Constitution and Federalism, January 13, 2023. Relating to scheduling Serdexmethylphenidate.
Submitted by the Controlled Substances Board.
hist161064Report received from Agency, January 3, 2023. hist161245Referred to the committee on Health, January 13, 2023. Relating to scheduling ten (10) fentanyl related substances.
Submitted by the Controlled Substances Board.
hist161063Report received from Agency, January 3, 2023. hist161246Referred to the committee on Health, January 13, 2023. Relating to scheduling Alfaxalone.
Submitted by the Controlled Substances Board.
hist161062Report received from Agency, January 3, 2023. hist161247Referred to the committee on Health, January 13, 2023. Relating to Excluding 6-beta-Naltrexol.
Submitted by the Controlled Substances Board.
hist161061Report received from Agency, January 3, 2023. hist161248Referred to the committee on Health, January 13, 2023. Relating to scheduling Fospropofol.
Submitted by the Controlled Substances Board.
hist161060Report received from Agency, January 3, 2023. hist161249Referred to the committee on Health, January 13, 2023. Relating to scheduling Embutramide.
Submitted by the Controlled Substances Board.
hist161059Report received from Agency, January 3, 2023. hist161250Referred to the committee on Health, January 13, 2023. Relating to scheduling Perampanel.
Submitted by the Controlled Substances Board.
hist161058Report received from Agency, January 3, 2023. hist161251Referred to the committee on Health, January 13, 2023. Relating to scheduling Lacosamide.
Submitted by the Controlled Substances Board.
hist161057Report received from Agency, January 3, 2023. hist161252Referred to the committee on Health, January 13, 2023. Relating to transferring 1-phenylcyclohexylamine and 1-piperidinocyclohexanecarbonitrile, immediate precursors to phencyclidine, also known as PCP.
Submitted by the Controlled Substances Board.
hist161056Report received from Agency, January 3, 2023. hist161253Referred to the committee on Health, January 13, 2023. Relating to general updates.
Submitted by the Department of Veterans Affairs.
hist161055Report received from Agency, January 3, 2023. hist161254Referred to the committee on Labor, Regulatory Reform, Veterans and Military Affairs, January 13, 2023. Relating to the employment and entrepreneurship grants transition program.
Submitted by the Department of Veterans Affairs.
hist161054Report received from Agency, January 3, 2023. hist161255Referred to the committee on Labor, Regulatory Reform, Veterans and Military Affairs, January 13, 2023. Relating to telehealth.
Submitted by the Department of Health Services.
hist161053Report received from Agency, January 3, 2023. hist161256Referred to the committee on Health, January 13, 2023. Relating to the Clean Water Fund Program.
Submitted by the Department of Natural Resources.
hist161052Report received from Agency, January 3, 2023. hist161257Referred to the committee on Natural Resources and Energy, January 13, 2023. Relating to SeniorCare Prescription Drugs.
Submitted by the Department of Health Services.
hist161051Report received from Agency, January 3, 2023.
